NasdaqCM:VKTXBiotechs
Viking Therapeutics Adds New CMO As Pipeline Progress And Valuation Scrutinized
Viking Therapeutics (NasdaqCM:VKTX) has appointed Dr. Hubert C. Chen as chief medical officer.
Dr. Chen brings extensive experience in drug discovery, clinical development, and regulatory strategy.
The appointment expands the company’s senior leadership as its pipeline of metabolic and endocrine therapies progresses.
Viking Therapeutics focuses on developing therapies for metabolic and endocrine disorders, areas that continue to attract attention as obesity, liver disease, and related...